{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T04:02:05Z","timestamp":1784088125157,"version":"3.55.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T00:00:00Z","timestamp":1557273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T00:00:00Z","timestamp":1557273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2016YFF0101400"],"award-info":[{"award-number":["2016YFF0101400"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81571614"],"award-info":[{"award-number":["81571614"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroimmune Pharmacol"],"published-print":{"date-parts":[[2019,9,15]]},"DOI":"10.1007\/s11481-019-09843-4","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T07:14:34Z","timestamp":1557299674000},"page":"478-492","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["FTY720 Inhibits MPP+-Induced Microglial Activation by Affecting NLRP3 Inflammasome Activation"],"prefix":"10.1007","volume":"14","author":[{"given":"Shu","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,8]]},"reference":[{"key":"9843_CR1","doi-asserted-by":"publisher","first-page":"787","DOI":"10.4049\/jimmunol.0901363","volume":"183","author":"FG Bauernfeind","year":"2009","unstructured":"Bauernfeind FG, Horvath G, Stutz A, Alnemri ES, MacDonald K, Speert D, Fernandes-Alnemri T, Wu J, Monks BG, Fitzgerald KA, Hornung V, Latz E (2009) Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol 183:787\u2013791","journal-title":"J Immunol"},{"key":"9843_CR2","doi-asserted-by":"publisher","first-page":"5938","DOI":"10.1523\/JNEUROSCI.1547-09.2009","volume":"29","author":"NP Belichenko","year":"2009","unstructured":"Belichenko NP, Belichenko PV, Kleschevnikov AM, Salehi A, Reeves RH, Mobley WC (2009) The \"down syndrome critical region\" is sufficient in the mouse model to confer behavioral, neurophysiological, and synaptic phenotypes characteristic of down syndrome. J Neurosci 29:5938\u20135948","journal-title":"J Neurosci"},{"key":"9843_CR3","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1097\/00001756-200312190-00025","volume":"14","author":"GN Bijur","year":"2003","unstructured":"Bijur GN, Jope RS (2003) Glycogen synthase kinase-3 beta is highly activated in nuclei and mitochondria. Neuroreport 14:2415\u20132419","journal-title":"Neuroreport"},{"key":"9843_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrn2038","volume":"8","author":"ML Block","year":"2007","unstructured":"Block ML, Zecca L, Hong JS (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8:57\u201369","journal-title":"Nat Rev Neurosci"},{"key":"9843_CR5","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1111\/j.1476-5381.2009.00451.x","volume":"158","author":"V Brinkmann","year":"2009","unstructured":"Brinkmann V (2009) FTY720 (fingolimod) in multiple sclerosis: therapeutic effects in the immune and the central nervous system. Br J Pharmacol 158:1173\u20131182","journal-title":"Br J Pharmacol"},{"key":"9843_CR6","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12974-018-1169-6","volume":"15","author":"K Cao","year":"2018","unstructured":"Cao K, Liao X, Lu J, Yao S, Wu F, Zhu X, Shi D, Wen S, Liu L, Zhou H (2018) IL-33\/ST2 plays a critical role in endothelial cell activation and microglia-mediated neuroinflammation modulation. J Neuroinflammation 15:136","journal-title":"J Neuroinflammation"},{"key":"9843_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2018.08.002","volume":"169","author":"Z Chen","year":"2018","unstructured":"Chen Z, Chen S, Liu J (2018) The role of T cells in the pathogenesis of Parkinson's disease. Prog Neurobiol 169:1\u201323","journal-title":"Prog Neurobiol"},{"key":"9843_CR8","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.intimp.2016.05.007","volume":"36","author":"A Cianciulli","year":"2016","unstructured":"Cianciulli A, Calvello R, Porro C, Trotta T, Salvatore R, Panaro MA (2016) PI3k\/Akt signalling pathway plays a crucial role in the anti-inflammatory effects of curcumin in LPS-activated microglia. Int Immunopharmacol 36:282\u2013290","journal-title":"Int Immunopharmacol"},{"key":"9843_CR9","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nm.3806","volume":"21","author":"RC Coll","year":"2015","unstructured":"Coll RC, Robertson AA, Chae JJ, Higgins SC, Munoz-Planillo R, Inserra MC, Vetter I, Dungan LS, Monks BG, Stutz A, Croker DE, Butler MS, Haneklaus M, Sutton CE, Nunez G, Latz E, Kastner DL, Mills KH, Masters SL, Schroder K, Cooper MA, O'Neill LA (2015) A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat Med 21:248\u2013255","journal-title":"Nat Med"},{"key":"9843_CR10","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1185\/03007995.2016.1162774","volume":"32","author":"I Cristobal","year":"2016","unstructured":"Cristobal I, Madoz-Gurpide J, Manso R, Gonzalez-Alonso P, Rojo F, Garcia-Foncillas J (2016) Potential anti-tumor effects of FTY720 associated with PP2A activation: a brief review. Curr Med Res Opin 32:1137\u20131141","journal-title":"Curr Med Res Opin"},{"key":"9843_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuropharm.2017.03.034","volume":"119","author":"A Das","year":"2017","unstructured":"Das A, Arifuzzaman S, Kim SH, Lee YS, Jung KH, Chai YG (2017) FTY720 (fingolimod) regulates key target genes essential for inflammation in microglial cells as defined by high-resolution mRNA sequencing. Neuropharmacology 119:1\u201314","journal-title":"Neuropharmacology"},{"key":"9843_CR12","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1007\/s11481-017-9754-5","volume":"12","author":"V Deora","year":"2017","unstructured":"Deora V, Albornoz EA, Zhu K, Woodruff TM, Gordon R (2017) The ketone body \u03b2-Hydroxybutyrate does not inhibit Synuclein mediated Inflammasome activation in microglia. J NeuroImmune Pharmacol 12:568\u2013574","journal-title":"J NeuroImmune Pharmacol"},{"key":"9843_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phrs.2012.10.004","volume":"67","author":"L Di Menna","year":"2013","unstructured":"Di Menna L, Molinaro G, Di Nuzzo L, Riozzi B, Zappulla C, Pozzilli C, Turrini R, Caraci F, Copani A, Battaglia G, Nicoletti F, Bruno V (2013) Fingolimod protects cultured cortical neurons against excitotoxic death. Pharmacol Res 67:1\u20139","journal-title":"Pharmacol Res"},{"key":"9843_CR14","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1093\/hmg\/ddt615","volume":"23","author":"A Di Pardo","year":"2014","unstructured":"Di Pardo A, Amico E, Favellato M, Castrataro R, Fucile S, Squitieri F, Maglione V (2014) FTY720 (fingolimod) is a neuroprotective and disease-modifying agent in cellular and mouse models of Huntington disease. Hum Mol Genet 23:2251\u20132265","journal-title":"Hum Mol Genet"},{"key":"9843_CR15","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12974-014-0140-4","volume":"11","author":"H Dong","year":"2014","unstructured":"Dong H, Zhang X, Dai X, Lu S, Gui B, Jin W, Zhang S, Zhang S, Qian Y (2014) Lithium ameliorates lipopolysaccharide-induced microglial activation via inhibition of toll-like receptor 4 expression by activating the PI3K\/Akt\/FoxO1 pathway. J Neuroinflammation 11:140","journal-title":"J Neuroinflammation"},{"key":"9843_CR16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.pbb.2012.08.025","volume":"103","author":"F Gao","year":"2012","unstructured":"Gao F, Liu Y, Li X, Wang Y, Wei D, Jiang W (2012) Fingolimod (FTY720) inhibits neuroinflammation and attenuates spontaneous convulsions in lithium-pilocarpine induced status epilepticus in rat model. Pharmacol Biochem Behav 103:187\u2013196","journal-title":"Pharmacol Biochem Behav"},{"key":"9843_CR17","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/imm.12272","volume":"142","author":"CS Garris","year":"2014","unstructured":"Garris CS, Blaho VA, Hla T, Han MH (2014) Sphingosine-1-phosphate receptor 1 signalling in T cells: trafficking and beyond. Immunology 142:347\u2013353","journal-title":"Immunology"},{"key":"9843_CR18","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/ni.1636","volume":"9","author":"A Halle","year":"2008","unstructured":"Halle A, Hornung V, Petzold GC, Stewart CR, Monks BG, Reinheckel T, Fitzgerald KA, Latz E, Moore KJ, Golenbock DT (2008) The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol 9:857\u2013865","journal-title":"Nat Immunol"},{"key":"9843_CR19","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1161\/STROKEAHA.109.568899","volume":"41","author":"Y Hasegawa","year":"2010","unstructured":"Hasegawa Y, Suzuki H, Sozen T, Rolland W, Zhang JH (2010) Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats. Stroke 41:368\u2013374","journal-title":"Stroke"},{"key":"9843_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.expneurol.2015.05.002","volume":"271","author":"A Heinen","year":"2015","unstructured":"Heinen A, Beyer F, Tzekova N, Hartung HP, Kury P (2015) Fingolimod induces the transition to a nerve regeneration promoting Schwann cell phenotype. Exp Neurol 271:25\u201335","journal-title":"Exp Neurol"},{"key":"9843_CR21","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.bbr.2013.06.016","volume":"252","author":"F Hemmati","year":"2013","unstructured":"Hemmati F, Dargahi L, Nasoohi S, Omidbakhsh R, Mohamed Z, Chik Z, Naidu M, Ahmadiani A (2013) Neurorestorative effect of FTY720 in a rat model of Alzheimer's disease: comparison with memantine. Behav Brain Res 252:415\u2013421","journal-title":"Behav Brain Res"},{"key":"9843_CR22","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature11729","volume":"493","author":"MT Heneka","year":"2013","unstructured":"Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A, Griep A, Axt D, Remus A, Tzeng TC, Gelpi E, Halle A, Korte M, Latz E, Golenbock DT (2013) NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP\/PS1 mice. Nature 493:674\u2013678","journal-title":"Nature"},{"key":"9843_CR23","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.intimp.2015.11.024","volume":"30","author":"H Hou","year":"2016","unstructured":"Hou H, Cao R, Miao J, Sun Y, Liu X, Song X, Guo L (2016) Fingolimod ameliorates the development of experimental autoimmune encephalomyelitis by inhibiting Akt-mTOR axis in mice. Int Immunopharmacol 30:171\u2013178","journal-title":"Int Immunopharmacol"},{"key":"9843_CR24","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s40263-015-0297-0","volume":"30","author":"SF Hunter","year":"2016","unstructured":"Hunter SF, Bowen JD, Reder AT (2016) The direct effects of Fingolimod in the central nervous system: implications for relapsing multiple sclerosis. CNS Drugs 30:135\u2013147","journal-title":"CNS Drugs"},{"key":"9843_CR25","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1742-2094-8-76","volume":"8","author":"SJ Jackson","year":"2011","unstructured":"Jackson SJ, Giovannoni G, Baker D (2011) Fingolimod modulates microglial activation to augment markers of remyelination. J Neuroinflammation 8:76","journal-title":"J Neuroinflammation"},{"key":"9843_CR26","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/glia.22454","volume":"61","author":"Y Jamilloux","year":"2013","unstructured":"Jamilloux Y, Pierini R, Querenet M, Juruj C, Fauchais AL, Jauberteau MO, Jarraud S, Lina G, Etienne J, Roy CR, Henry T, Davoust N, Ader F (2013) Inflammasome activation restricts legionella pneumophila replication in primary microglial cells through flagellin detection. Glia 61:539\u2013549","journal-title":"Glia"},{"key":"9843_CR27","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s11064-006-9128-5","volume":"32","author":"RS Jope","year":"2007","unstructured":"Jope RS, Yuskaitis CJ, Beurel E (2007) Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics. Neurochem Res 32:577\u2013595","journal-title":"Neurochem Res"},{"key":"9843_CR28","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1056\/NEJMoa0909494","volume":"362","author":"L Kappos","year":"2010","unstructured":"Kappos L, Radue EW, O'Connor P, Polman C, Hohlfeld R, Calabresi P, Selmaj K, Agoropoulou C, Leyk M, Zhang-Auberson L, Burtin P (2010) A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N Engl J Med 362:387\u2013401","journal-title":"N Engl J Med"},{"key":"9843_CR29","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s11481-017-9766-1","volume":"13","author":"D Kempuraj","year":"2017","unstructured":"Kempuraj D, Selvakumar GP, Zaheer S, Thangavel R, Ahmed ME, Raikwar S, Govindarajan R, Iyer S, Zaheer A (2017) Cross-talk between glia, neurons and mast cells in Neuroinflammation associated with Parkinson's disease. J NeuroImmune Pharmacol 13:100\u2013112","journal-title":"J NeuroImmune Pharmacol"},{"key":"9843_CR30","doi-asserted-by":"publisher","first-page":"7015","DOI":"10.4049\/jimmunol.172.11.7015","volume":"172","author":"WK Kim","year":"2004","unstructured":"Kim WK, Hwang SY, Oh ES, Piao HZ, Kim KW, Han IO (2004) TGF-beta1 represses activation and resultant death of microglia via inhibition of phosphatidylinositol 3-kinase activity. J Immunol 172:7015\u20137023","journal-title":"J Immunol"},{"key":"9843_CR31","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/BF03033861","volume":"14","author":"TD King","year":"2008","unstructured":"King TD, Clodfelder-Miller B, Barksdale KA, Bijur GN (2008) Unregulated mitochondrial GSK3beta activity results in NADH: ubiquinone oxidoreductase deficiency. Neurotox Res 14:367\u2013382","journal-title":"Neurotox Res"},{"key":"9843_CR32","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.lfs.2015.07.017","volume":"137","author":"K Kinoshita","year":"2015","unstructured":"Kinoshita K, Tada Y, Muroi Y, Unno T, Ishii T (2015) Selective loss of dopaminergic neurons in the substantia nigra pars compacta after systemic administration of MPTP facilitates extinction learning. Life Sci 137:28\u201336","journal-title":"Life Sci"},{"key":"9843_CR33","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nri3452","volume":"13","author":"E Latz","year":"2013","unstructured":"Latz E, Xiao TS, Stutz A (2013) Activation and regulation of the inflammasomes. Nat Rev Immunol 13:397\u2013411","journal-title":"Nat Rev Immunol"},{"key":"9843_CR34","doi-asserted-by":"publisher","first-page":"14913","DOI":"10.18632\/oncotarget.3818","volume":"6","author":"H Liu","year":"2015","unstructured":"Liu H, Gu Y, Wang H, Yin J, Zheng G, Zhang Z, Lu M, Wang C, He Z (2015a) Overexpression of PP2A inhibitor SET oncoprotein is associated with tumor progression and poor prognosis in human non-small cell lung cancer. Oncotarget 6:14913\u201314925","journal-title":"Oncotarget"},{"key":"9843_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/srep15720","volume":"5","author":"J Liu","year":"2015","unstructured":"Liu J, Huang D, Xu J, Tong J, Wang Z, Huang L, Yang Y, Bai X, Wang P, Suo H, Ma Y, Yu M, Fei J, Huang F (2015b) Tiagabine protects dopaminergic neurons against neurotoxins by inhibiting microglial activation. Sci Rep 5:15720","journal-title":"Sci Rep"},{"key":"9843_CR36","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.bbi.2015.08.006","volume":"51","author":"Z Liu","year":"2016","unstructured":"Liu Z, Chen HQ, Huang Y, Qiu YH, Peng YP (2016) Transforming growth factor-beta1 acts via TbetaR-I on microglia to protect against MPP(+)-induced dopaminergic neuronal loss. Brain Behav Immun 51:131\u2013143","journal-title":"Brain Behav Immun"},{"key":"9843_CR37","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/ni1221","volume":"6","author":"M Martin","year":"2005","unstructured":"Martin M, Rehani K, Jope RS, Michalek SM (2005) Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat Immunol 6:777\u2013784","journal-title":"Nat Immunol"},{"key":"9843_CR38","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1146\/annurev-genom-082410-101440","volume":"12","author":"I Martin","year":"2011","unstructured":"Martin I, Dawson VL, Dawson TM (2011) Recent advances in the genetics of Parkinson's disease. Annu Rev Genomics Hum Genet 12:301\u2013325","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"9843_CR39","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1007\/s11481-017-9753-6","volume":"12","author":"RM McManus","year":"2017","unstructured":"McManus RM, Finucane OM, Wilk MM, Mills K, Lynch MA (2017) FTY720 attenuates infection-induced enhancement of Abeta accumulation in APP\/PS1 mice by modulating astrocytic activation. J NeuroImmune Pharmacol 12:670\u2013681","journal-title":"J NeuroImmune Pharmacol"},{"key":"9843_CR40","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1177\/1352458511411061","volume":"17","author":"X Montalban","year":"2011","unstructured":"Montalban X, Comi G, O'Connor P, Gold S, de Vera A, Eckert B, Kappos L (2011) Oral fingolimod (FTY720) in relapsing multiple sclerosis: impact on health-related quality of life in a phase II study. Mult Scler 17:1341\u20131350","journal-title":"Mult Scler"},{"key":"9843_CR41","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.3892\/ijmm.2013.1528","volume":"32","author":"MH Moon","year":"2013","unstructured":"Moon MH, Jeong JK, Lee YJ, Park SY (2013) FTY720 protects neuronal cells from damage induced by human prion protein by inactivating the JNK pathway. Int J Mol Med 32:1387\u20131393","journal-title":"Int J Mol Med"},{"key":"9843_CR42","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3892\/ijmm.2016.2833","volume":"39","author":"N Nakano","year":"2017","unstructured":"Nakano N, Matsuda S, Ichimura M, Minami A, Ogino M, Murai T, Kitagishi Y (2017) PI3K\/AKT signaling mediated by G proteincoupled receptors is involved in neurodegenerative Parkinson's disease (review). Int J Mol Med 39:253\u2013260","journal-title":"Int J Mol Med"},{"key":"9843_CR43","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jneuroim.2012.12.005","volume":"256","author":"H Noda","year":"2013","unstructured":"Noda H, Takeuchi H, Mizuno T, Suzumura A (2013) Fingolimod phosphate promotes the neuroprotective effects of microglia. J Neuroimmunol 256:13\u201318","journal-title":"J Neuroimmunol"},{"key":"9843_CR44","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1016\/j.ajpath.2011.12.012","volume":"180","author":"Y Norimatsu","year":"2012","unstructured":"Norimatsu Y, Ohmori T, Kimura A, Madoiwa S, Mimuro J, Seichi A, Yatomi Y, Hoshino Y, Sakata Y (2012) FTY720 improves functional recovery after spinal cord injury by primarily nonimmunomodulatory mechanisms. Am J Pathol 180:1625\u20131635","journal-title":"Am J Pathol"},{"key":"9843_CR45","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10072-017-3154-8","volume":"39","author":"C Papagno","year":"2018","unstructured":"Papagno C, Trojano L (2018) Cognitive and behavioral disorders in Parkinson's disease: an update. I: cognitive impairments. Neurol Sci 39:215\u2013223","journal-title":"Neurol Sci"},{"issue":"Suppl 1","key":"9843_CR46","doi-asserted-by":"publisher","first-page":"S207","DOI":"10.1016\/S1353-8020(11)70064-5","volume":"18","author":"S Phani","year":"2012","unstructured":"Phani S, Loike JD, Przedborski S (2012) Neurodegeneration and inflammation in Parkinson's disease. Parkinsonism Relat Disord 18(Suppl 1):S207\u2013S209","journal-title":"Parkinsonism Relat Disord"},{"key":"9843_CR47","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.bbi.2018.09.001","volume":"75","author":"L Poh","year":"2018","unstructured":"Poh L, Kang SW, Baik SH, Ng GYQ, She DT, Balaganapathy P, Dheen ST, Magnus T, Gelderblom M, Sobey CG, Koo EH, Fann DY, Arumugam TV (2018) Evidence that NLRC4 inflammasome mediates apoptotic and pyroptotic microglial death following ischemic stroke. Brain Behav Immun 75:34\u201347. https:\/\/doi.org\/10.1016\/j.bbi.2018.09.001. [Epub ahead of print","journal-title":"Brain Behav Immun"},{"key":"9843_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/srep37297","volume":"6","author":"MM Rahman","year":"2016","unstructured":"Rahman MM, Prunte L, Lebender LF, Patel BS, Gelissen I, Hansbro PM, Morris JC, Clark AR, Verrills NM, Ammit AJ (2016) The phosphorylated form of FTY720 activates PP2A, represses inflammation and is devoid of S1P agonism in A549 lung epithelial cells. Sci Rep 6:37297","journal-title":"Sci Rep"},{"key":"9843_CR49","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1007\/s11064-016-2125-4","volume":"42","author":"M Ren","year":"2017","unstructured":"Ren M, Han M, Wei X, Guo Y, Shi H, Zhang X, Perez RG, Lou H (2017) FTY720 attenuates 6-OHDA-associated dopaminergic degeneration in cellular and mouse parkinsonian models. Neurochem Res 42:686\u2013696","journal-title":"Neurochem Res"},{"key":"9843_CR50","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/978-3-7091-0693-8_36","volume":"111","author":"WN Rolland","year":"2011","unstructured":"Rolland WN, Manaenko A, Lekic T, Hasegawa Y, Ostrowski R, Tang J, Zhang JH (2011) FTY720 is neuroprotective and improves functional outcomes after intracerebral hemorrhage in mice. Acta Neurochir Suppl 111:213\u2013217","journal-title":"Acta Neurochir Suppl"},{"key":"9843_CR51","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.expneurol.2012.12.009","volume":"241","author":"WB Rolland","year":"2013","unstructured":"Rolland WB, Lekic T, Krafft PR, Hasegawa Y, Altay O, Hartman R, Ostrowski R, Manaenko A, Tang J, Zhang JH (2013) Fingolimod reduces cerebral lymphocyte infiltration in experimental models of rodent intracerebral hemorrhage. Exp Neurol 241:45\u201355","journal-title":"Exp Neurol"},{"key":"9843_CR52","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1038\/cddis.2013.455","volume":"4","author":"C Rutherford","year":"2013","unstructured":"Rutherford C, Childs S, Ohotski J, McGlynn L, Riddick M, MacFarlane S, Tasker D, Pyne S, Pyne NJ, Edwards J, Palmer TM (2013) Regulation of cell survival by sphingosine-1-phosphate receptor S1P1 via reciprocal ERK-dependent suppression of Bim and PI-3-kinase\/protein kinase C-mediated upregulation of Mcl-1. Cell Death Dis 4:e927","journal-title":"Cell Death Dis"},{"key":"9843_CR53","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41531-017-0032-2","volume":"3","author":"S Sarkar","year":"2017","unstructured":"Sarkar S, Malovic E, Harishchandra DS, Ghaisas S, Panicker N, Charli A, Palanisamy BN, Rokad D, Jin H, Anantharam V, Kanthasamy A, Kanthasamy AG (2017) Mitochondrial impairment in microglia amplifies NLRP3 inflammasome proinflammatory signaling in cell culture and animal models of Parkinson's disease. NPJ Parkinsons Dis 3:30","journal-title":"NPJ Parkinsons Dis"},{"key":"9843_CR54","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1002\/pros.21285","volume":"71","author":"Y Sekine","year":"2011","unstructured":"Sekine Y, Suzuki K, Remaley AT (2011) HDL and sphingosine-1-phosphate activate stat3 in prostate cancer DU145 cells via ERK1\/2 and S1P receptors, and promote cell migration and invasion. Prostate 71:690\u2013699","journal-title":"Prostate"},{"key":"9843_CR55","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/nm.1999","volume":"15","author":"T Shichita","year":"2009","unstructured":"Shichita T, Sugiyama Y, Ooboshi H, Sugimori H, Nakagawa R, Takada I, Iwaki T, Okada Y, Iida M, Cua DJ, Iwakura Y, Yoshimura A (2009) Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury. Nat Med 15:946\u2013950","journal-title":"Nat Med"},{"key":"9843_CR56","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/9671732","volume":"2016","author":"B Tan","year":"2016","unstructured":"Tan B, Luo Z, Yue Y, Liu Y, Pan L, Yu L, Yin Y (2016) Effects of FTY720 (Fingolimod) on proliferation, differentiation, and migration of brain-derived neural stem cells. Stem Cells Int 2016:9671732","journal-title":"Stem Cells Int"},{"key":"9843_CR57","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s12035-014-9070-5","volume":"53","author":"Y Tang","year":"2016","unstructured":"Tang Y, Le W (2016) Differential roles of M1 and M2 microglia in neurodegenerative diseases. Mol Neurobiol 53:1181\u20131194","journal-title":"Mol Neurobiol"},{"key":"9843_CR58","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.nbd.2009.11.004","volume":"37","author":"MG Tansey","year":"2010","unstructured":"Tansey MG, Goldberg MS (2010) Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention. Neurobiol Dis 37:510\u2013518","journal-title":"Neurobiol Dis"},{"key":"9843_CR59","doi-asserted-by":"publisher","first-page":"8778","DOI":"10.1128\/MCB.24.19.8778-8789.2004","volume":"24","author":"S Ugi","year":"2004","unstructured":"Ugi S, Imamura T, Maegawa H, Egawa K, Yoshizaki T, Shi K, Obata T, Ebina Y, Kashiwagi A, Olefsky JM (2004) Protein phosphatase 2A negatively regulates insulin's metabolic signaling pathway by inhibiting Akt (protein kinase B) activity in 3T3-L1 adipocytes. Mol Cell Biol 24:8778\u20138789","journal-title":"Mol Cell Biol"},{"key":"9843_CR60","unstructured":"van Horssen J, van Schaik P, Witte M (2017) Inflammation and mitochondrial dysfunction: a vicious circle in neurodegenerative disorders? Neurosci Lett"},{"key":"9843_CR61","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1002\/jcp.26001","volume":"233","author":"BK Velmurugan","year":"2018","unstructured":"Velmurugan BK, Lee CH, Chiang SL, Hua CH, Chen MC, Lin SH, Yeh KT, Ko YC (2018) PP2A deactivation is a common event in oral cancer and reactivation by FTY720 shows promising therapeutic potential. J Cell Physiol 233:1300\u20131311","journal-title":"J Cell Physiol"},{"key":"9843_CR62","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nrn.2017.130","volume":"18","author":"ND Volkow","year":"2017","unstructured":"Volkow ND, Wise RA, Baler R (2017) The dopamine motive system: implications for drug and food addiction. Nat Rev Neurosci 18:741\u2013752","journal-title":"Nat Rev Neurosci"},{"key":"9843_CR63","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/ana.22186","volume":"69","author":"Y Wei","year":"2011","unstructured":"Wei Y, Yemisci M, Kim HH, Yung LM, Shin HK, Hwang SK, Guo S, Qin T, Alsharif N, Brinkmann V, Liao JK, Lo EH, Waeber C (2011) Fingolimod provides long-term protection in rodent models of cerebral ischemia. Ann Neurol 69:119\u2013129","journal-title":"Ann Neurol"},{"key":"9843_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.toxlet.2018.02.003","volume":"288","author":"L Wen","year":"2018","unstructured":"Wen L, Zhang QS, Heng Y, Chen Y, Wang S, Yuan YH, Chen NH (2018) NLRP3 inflammasome activation in the thymus of MPTP-induced parkinsonian mouse model. Toxicol Lett 288:1\u20138","journal-title":"Toxicol Lett"},{"key":"9843_CR65","doi-asserted-by":"publisher","first-page":"6145","DOI":"10.1073\/pnas.0937239100","volume":"100","author":"DC Wu","year":"2003","unstructured":"Wu DC, Teismann P, Tieu K, Vila M, Jackson-Lewis V, Ischiropoulos H, Przedborski S (2003) NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. Proc Natl Acad Sci U S A 100:6145\u20136150","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9843_CR66","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1742-2094-10-41","volume":"10","author":"C Wu","year":"2013","unstructured":"Wu C, Leong SY, Moore CS, Cui QL, Gris P, Bernier LP, Johnson TA, Seguela P, Kennedy TE, Bar-Or A, Antel JP (2013) Dual effects of daily FTY720 on human astrocytes in vitro: relevance for neuroinflammation. J Neuroinflammation 10:41","journal-title":"J Neuroinflammation"},{"key":"9843_CR67","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s12974-018-1299-x","volume":"15","author":"L Yin","year":"2018","unstructured":"Yin L, Bao F, Wu J, Li K (2018) NLRP3 inflammasome-dependent pyroptosis is proposed to be involved in the mechanism of age-dependent isoflurane-induced cognitive impairment. J Neuroinflammation 15:266","journal-title":"J Neuroinflammation"},{"key":"9843_CR68","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1159\/000068403","volume":"67","author":"B Zassler","year":"2003","unstructured":"Zassler B, Schermer C, Humpel C (2003) Protein kinase C and phosphoinositol-3-kinase mediate differentiation or proliferation of slice-derived rat microglia. Pharmacology 67:211\u2013215","journal-title":"Pharmacology"},{"key":"9843_CR69","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.intimp.2018.09.046","volume":"65","author":"M Zhang","year":"2018","unstructured":"Zhang M, Wu Y, Xie L, Teng CH, Wu FF, Xu KB, Chen X, Xiao J, Zhang HY, Chen DQ (2018) Isoliquiritigenin protects against blood-brain barrier damage and inhibits the secretion of pro-inflammatory cytokines in mice after traumatic brain injury. Int Immunopharmacol 65:64\u201375","journal-title":"Int Immunopharmacol"},{"key":"9843_CR70","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1096\/fj.201600751r","volume":"31","author":"P Zhao","year":"2017","unstructured":"Zhao P, Yang X, Yang L, Li M, Wood K, Liu Q, Zhu X (2017a) Neuroprotective effects of fingolimod in mouse models of Parkinson's disease. FASEB J 31:172\u2013179","journal-title":"FASEB J"},{"key":"9843_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000448837","volume":"137","author":"Z Zhao","year":"2017","unstructured":"Zhao Z, Wang R, Huo Z, Li C, Wang Z (2017b) Characterization of the anticoagulant and antithrombotic properties of the sphingosine 1-phosphate mimetic FTY720. Acta Haematol 137:1\u20136","journal-title":"Acta Haematol"},{"key":"9843_CR72","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature09663","volume":"469","author":"R Zhou","year":"2011","unstructured":"Zhou R, Yazdi AS, Menu P, Tschopp J (2011) A role for mitochondria in NLRP3 inflammasome activation. Nature 469:221\u2013225","journal-title":"Nature"}],"updated-by":[{"DOI":"10.1007\/s11481-024-10137-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:00:00Z","timestamp":1722902400000}}],"container-title":["Journal of Neuroimmune Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-019-09843-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11481-019-09843-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-019-09843-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T07:27:22Z","timestamp":1723015642000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11481-019-09843-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,8]]},"references-count":72,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9,15]]}},"alternative-id":["9843"],"URL":"https:\/\/doi.org\/10.1007\/s11481-019-09843-4","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s11481-024-10137-7","asserted-by":"object"}]},"ISSN":["1557-1890","1557-1904"],"issn-type":[{"value":"1557-1890","type":"print"},{"value":"1557-1904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,8]]},"assertion":[{"value":"31 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s11481-024-10137-7","URL":"https:\/\/doi.org\/10.1007\/s11481-024-10137-7","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interests"}}]}}